NYBC Ventures (investor - Corporate Investor)
See something wrong or missing? Let us know
Offices:Boston
NYBC Ventures is a $50 million invesment arm operated by the New York Blood Center in USA
Average round investment:44M USD
Average number per year:1.0
Distribution:
2026 (1)2025 (1)2024 (1)
Portfolio companies:
Vitestro
Cellular Origins
Vitestro
Cellular Origins
Mostly invests in:
Netherlands (2)
Manufacturing (3)
Netherlands (2)
Manufacturing (3)
3 tracked investments in:
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Investors with similar profile to NYBC Ventures
| Name | Criteria | |
|---|---|---|
![]() |
Committed Capital
83%
|
|
![]() |
GT Healthcare Capital
83%
|
|
![]() |
Fine Structure Ventures
83%
|
|
![]() |
ALSA Ventures
83%
|
|
![]() |
Yamaha Motor Ventures
83%
|
|
![]() |
The Nature Conservancy
83%
|
|
![]() |
Aidan Gomez
83%
|
|
![]() |
Labcorp
83%
|
|
![]() |
kineo finance
83%
|
|
![]() |
Move Capital
83%
|
|





Belgium
Austria
Germany
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
Ireland
Italy
Portugal
Spain